Acyclovir Duration for Herpes Zoster
For immunocompetent adults with herpes zoster, treat with acyclovir 800 mg orally 5 times daily for 7 to 10 days, while immunocompromised patients require prolonged therapy up to 14 days or until complete clinical resolution. 1
Standard Duration for Immunocompetent Patients
The FDA-approved regimen is acyclovir 800 mg orally 5 times daily for 7 to 10 days 1. This duration is supported by multiple clinical trials demonstrating efficacy in reducing:
- Time to new lesion formation
- Duration of viral shedding
- Time to complete crusting and healing
- Acute pain severity 2, 3
Critical timing consideration: Treatment must be initiated within 72 hours of rash onset for maximum benefit, ideally within 48 hours 2, 3. Starting therapy beyond 48 hours shows no significant acceleration of rash healing, though pain reduction may still occur 2.
Adjustments for Immunocompromised Patients
Immunocompromised patients require more aggressive and prolonged therapy due to higher risk of dissemination and visceral complications 4, 5:
Oral Therapy (for localized disease):
- Duration: Continue until complete clinical resolution is attained, typically requiring longer than the standard 7-10 days 6
- Dose: Some experts recommend higher doses (acyclovir 800 mg 5 times daily) with close outpatient monitoring 5
- Monitoring: Requires frequent clinical assessment for signs of dissemination
Intravenous Therapy Indications:
Switch to IV acyclovir 10 mg/kg every 8 hours for up to 14 days when patients have 6:
- Disseminated cutaneous disease
- Visceral involvement (encephalitis, pneumonitis, hepatitis)
- Severe immunosuppression
- Inability to take oral medications
- Ophthalmic involvement 5
Important note: VZV is less sensitive to acyclovir than HSV. While 15 mg/kg three times daily has been suggested for normal renal function, most clinicians use 10 mg/kg with frequent renal monitoring 6.
Extensive Dermatomal Involvement
For extensive dermatomal involvement without dissemination in immunocompetent patients:
- Continue standard oral dosing (800 mg 5 times daily)
- Extend duration toward the 10-day end of the range or until all lesions are fully crusted
- Consider hospitalization if pain control is inadequate or patient cannot maintain oral intake
Renal Impairment Adjustments
Mandatory dose adjustments based on creatinine clearance 1:
| Creatinine Clearance | Adjusted Regimen |
|---|---|
| >25 mL/min | 800 mg every 4 hours, 5x daily |
| 10-25 mL/min | 800 mg every 8 hours |
| 0-10 mL/min | 800 mg every 12 hours |
Hemodialysis patients: Administer additional dose after each dialysis session due to 60% decrease in plasma concentrations during 6-hour dialysis 1.
Common Pitfalls to Avoid
Don't extend therapy to 21 days routinely: A randomized trial showed 21-day acyclovir courses offer only slight benefits over 7-day treatment with no reduction in postherpetic neuralgia 7
Don't delay treatment: Efficacy dramatically decreases when started >72 hours after rash onset 2, 3
Don't use topical acyclovir: Substantially less effective than oral therapy 8
Don't underdose in elderly: Elderly patients require standard dosing but need careful renal function monitoring and dose adjustment 1
Don't stop therapy prematurely in immunocompromised patients: These patients may require prolonged courses beyond 14 days if lesions haven't fully resolved 6
Acyclovir-Resistant Cases
If lesions persist or progress despite acyclovir therapy in immunocompromised patients, suspect resistance and switch to foscarnet 40 mg/kg IV every 8 hours until clinical resolution 9, 5.